Duke said the technician was fired in 2013 for embezzling money; she pleaded guilty to two counts of forgery and paid restitution to Duke.
The university then launched a formal scientific misconduct investigation into the technician's experiments. Her experiments involved measuring the lung function of laboratory mice. Duke says her research never involved humans.
Duke said during the seven years in question, the technician was part of 50 potentially compromised research grants.
"We expect Duke researchers to adhere always to the highest standards of integrity, and virtually all of them do that with great dedication," Duke University President Vincent E. Price said. "When individuals fail to uphold those standards, and those who are aware of possible wrongdoing fail to report it, as happened in this case, we must accept responsibility, acknowledge that our processes for identifying and preventing misconduct did not work, and take steps to improve."
Following the settlement, Duke agreed to implement the follow steps to help prevent fraud in the future.
- The appointment of a new Advisory Panel on Research Integrity and Excellence chaired by Ann M. Arvin, professor of pediatrics and microbiology and former vice provost and dean of research at Stanford University, and including Edward M. Stolper, William E. Leonhard Professor of Geology and former provost of Caltech, and Barry S. Coller, David Rockefeller Professor, physician in chief and vice president for medical affairs at Rockefeller University. The advisory panel will provide recommendations to President Price and university leadership for improving the structure and function of research administration, with a focus on promoting research integrity, by June 30, 2019.
- The establishment of a new, integrated leadership structure for research to provide clear and consistent policy guidance, oversight and accountability for all research at Duke University and Duke Health.
- A new initiative to promote values and a culture of excellence and accountability at Duke.
- The creation of an Executive Oversight Committee, chaired by Chancellor for Health Affairs A. Eugene Washington and including senior leadership and faculty, and a related Faculty Advisory Committee to oversee the ongoing implementation of Duke's research excellence initiative.